About Abirakast 250mg Tablet
Abirakast 250mg Tablet is a highly recommended and rare solution for advanced prostate cancer, boasting brilliant efficacy as a potent CYP17 inhibitor. Magnificently crafted for export quality, it procures superior results by inhibiting androgen biosynthesis. Each bottle contains 120 white to off-white film-coated tablets, administered orally and specifically formulated for adult men. This prescription-required medication aligns with lofty international standards and delivers consistent performance. Abirakast is odorless and should be stored away from light and moisture at temperatures below 30C, ensuring a remarkable shelf life of 24 months.
Why Choose Abirakast 250mg Tablet?
Abirakast 250mg Tablet is favored for its primary competitive advantage: potent CYP17 enzyme inhibition, delivering effective management of advanced prostate cancer. Suitable for adult men, it is administered orally, ensuring ease of use and precise dosage control. Crafted for reliable performance, Abirakast's export-quality formulation stands out among alternatives for its efficacy, safety, and compliance with international regulations, making it a preferred choice for oncology specialists.
Export, Delivery, and Freight Details for Abirakast 250mg Tablet
Abirakast 250mg Tablet ships from India's prominent FOB ports, supplied globally to main export markets across Asia, Africa, the Middle East, and Latin America. Exporters and suppliers maintain transparent sample policies and reliable freight options, ensuring products are delivered promptly and securely. Comprehensive support simplifies the delivery process, meeting various regulatory requirements and assuring customers of consistent availability and efficient shipment worldwide.
FAQ's of Abirakast 250mg Tablet:
Q: How should Abirakast 250mg Tablet be administered?
A: Abirakast 250mg Tablet is taken orally, typically as directed by a healthcare provider specializing in oncology. It is important to follow the prescribed dosage and administration schedule to achieve optimal therapeutic results.
Q: What are the storage conditions required for Abirakast 250mg Tablet?
A: The tablets should be stored below 30C in a dry place, away from light and moisture, as improper storage may affect their quality and efficacy.
Q: When is Abirakast 250mg Tablet indicated for use in patients?
A: Abirakast 250mg Tablet is indicated for adult men diagnosed with advanced prostate cancer, particularly when traditional therapies are no longer effective.
Q: Where can Abirakast 250mg Tablet be sourced or procured?
A: Abirakast 250mg Tablet is available through authorized exporters, suppliers, traders, and wholesalers in India, strictly on a prescription-only basis for international and domestic markets.
Q: What is the benefit of Abirakast's CYP17 inhibition in prostate cancer therapy?
A: By inhibiting the CYP17 enzyme, Abirakast reduces androgen production, which plays a significant role in the progression of advanced prostate cancer, thereby supporting improved patient outcomes as part of comprehensive cancer management.